“Serum” and “plasma” are specimen categories, not complete centrifuge programs. The usable method is defined by the tube, specimen state, downstream requirement, RCF, time, temperature and deceleration behavior.
Tube Instructions Come Before a Generic “Serum” or “Plasma” Setting
Different blood collection tubes may use different additives, separator materials, dimensions and processing requirements. Even tubes that ultimately produce serum or plasma do not automatically share the same clotting time, RCF, run time, temperature or braking condition.
A safer order for defining the centrifugation condition
Current tube instructions→Downstream method→Laboratory SOP→Centrifuge & rotor capability
Serum: Incomplete Clotting Cannot Be Corrected by More Centrifugal Force
Serum preparation includes a biological step before centrifugation: clot formation. If a sample enters the centrifuge before it reaches the state required by the tube instructions and laboratory method, simply increasing speed or extending the run does not convert an incomplete preanalytical process into a valid serum workflow.
Residual fibrin, continued clot formation or incomplete separation may still affect the sample after the rotor stops. The centrifuge therefore controls separation only after the specimen is ready for centrifugation.
Plasma: The Endpoint Is Defined by the Downstream Test
Plasma is prepared from anticoagulated blood, but “plasma” does not describe one universal quality target. Some downstream methods tolerate more residual cellular material than others, while other workflows may require low residual platelets or additional processing. The successful endpoint is plasma that meets the requirement of the downstream examination.
Why There Is No Universal Serum Setting or Plasma Setting
Published clinical and research methods use different combinations of centrifugal force, time and temperature because the conditions belong to the specific tube and analytical method—not to the words “serum” or “plasma.”
Decision Layer
Serum
Plasma
Pre-spin state
Required clot formation has occurred.
Blood remains anticoagulated.
Separation target
Liquid phase separated from clot/cellular material.
Liquid phase separated from cells to the quality required by the downstream method.
Residual cells/platelets and unsuitable anticoagulated specimen quality.
Parameter source
Tube instructions + validated laboratory method.
Tube instructions + downstream test requirement + validated method.
Transfer the Method by RCF, Not RPM Alone
RCF = 1.118 × 10 −5 × r × RPM 2
Two centrifuges running at the same RPM can produce different centrifugal force if their rotor radii differ.
When a tube or method specifies ×g, copying only the old RPM value to another rotor can change the actual specimen-processing condition.
If an older SOP records only RPM, a method transfer should first recover or calculate the original RCF from the original rotor geometry before selecting an equivalent setting on the new centrifuge.
Matching RCF Does Not Make Two Rotor Geometries Identical
Even when two rotors can achieve the same RCF, they may position the tube differently during the run and produce a different sediment or interface geometry. This matters when the post-spin interface itself affects sample handling.
Swing-Out Rotor
Flatter post-spin interface
Tubes move toward a horizontal position during operation. For many routine blood-tube workflows, this can create a flatter interface between liquid and sediment or separator material, simplifying downstream sampling.
Fixed-Angle Rotor
Different sediment and interface geometry
Fixed-angle loading changes the direction and position of sedimentation. It can be suitable when the exact tube and workflow have been validated, but it should not be assumed equivalent solely because the RCF matches.
Separator tubes make rotor geometry more important
In tubes containing separator material, centrifugation must do more than produce a clear upper liquid layer. The separator also has to migrate to the intended position and form a stable barrier between phases.
Braking Is a Method Variable, Not a Universal “On” or “Off” Rule
Deceleration continues to influence the specimen after maximum speed has ended. Some workflows may require gentler deceleration to protect a fragile interface or reduce remixing. Other validated tube workflows can use faster braking without compromising the specimen.
Too aggressive
Possible interface disturbance
Rapid deceleration can disturb loosely separated material in sensitive workflows.
Too conservative
Longer total batch cycle
Using the slowest possible deceleration when it is not required can reduce throughput without adding sample-quality benefit.
Correct approach
Use the validated profile
Braking should be defined by the specific tube and downstream method, not by a universal rule.
Temperature Should Follow the Method, Not the Specimen Name
Serum does not universally require low-temperature centrifugation, and plasma does not universally require room-temperature centrifugation. Temperature belongs to the specific method.
When the workflow requires controlled temperature, the equipment must reproduce that condition. When temperature is not a critical method variable, refrigeration does not automatically improve separation quality. See the GlanLab Refrigerated vs Non-Refrigerated Centrifuge guide for the temperature-selection framework.
A Reproducible Serum or Plasma Program Should Record More Than a Name
01
Tube Type
Additive, separator, geometry and relevant instructions.
02
Target Specimen
Serum, plasma or a more specific plasma-quality target.
03
RCF
Use the specified centrifugal force rather than copying RPM between rotors.
04
Run Time
Use the validated duration and define how timing is interpreted.
05
Temperature
Record temperature when it is part of the validated method.
06
Acceleration / Deceleration
Store the run behavior when it can affect the final interface.
GlanLab YT5A: Blood-Tube Capacity Is Only Useful When the Rotor Matches the Workflow
Clinical workflow capability should be evaluated at the rotor level
GlanLab YT5A provides up to 5,000 rpm and 4,730 ×g, with multiple swing-out rotor configurations for routine blood collection tubes and programmable acceleration/deceleration profiles.
The useful procurement question is not simply whether the centrifuge “can process blood.” It is whether the laboratory's actual tube format, required RCF, rotor geometry, batch size and braking profile can be matched to a validated program.
Revalidate the Workflow When a Method-Defining Variable Changes
Change 01
Tube Change
Additive, separator, dimensions or tube instructions may change the valid processing condition.
Change 02
Rotor Change
Radius, sedimentation geometry and post-spin interface can change even when nominal RCF is matched.
Change 03
Centrifuge Change
Do not copy an old RPM setting without confirming equivalent RCF and rotor geometry.
Change 04
Temperature Change
Temperature can affect the specimen and, in some workflows, separation behavior.
Change 05
Braking Change
Deceleration behavior can alter the final interface or residual particulate content.
Change 06
Downstream Test Change
A specimen still called “plasma” may need a different residual platelet or cellular profile.
A Clear-Looking Supernatant Is Not the Same as a Qualified Specimen
Visual separation can confirm that major phases have separated, but it cannot by itself establish that serum or plasma meets the downstream analytical requirement.
What May Still Matter After a Visually Successful Spin
Why It Matters
Residual cells
May influence downstream analytical quality or stability.
Residual platelets
Can be critical in plasma workflows with stricter platelet requirements.
Residual fibrin
May indicate incomplete serum preparation or later clot formation risk.
Hemolysis
Can affect multiple downstream measurements even when the liquid phase looks clear.
Separator barrier quality
Determines whether the liquid fraction remains reliably isolated from underlying material.
Use the Workflow to Choose the Centrifuge—not the Other Way Around
01
Define serum or plasma target
Clarify the required specimen and downstream quality requirement.
02
Identify the exact tube
Use current tube instructions rather than a generic blood-tube assumption.
03
Set RCF and time
Use the validated force and duration required by the workflow.
04
Confirm rotor geometry
Check both centrifugal force and the post-spin interface produced by the rotor.
05
Define temperature and braking
Only use these conditions when they are part of the validated method.
06
Match equipment to the program
Choose the centrifuge and rotor that can reproduce the entire workflow consistently.
Serum and Plasma Are Two Different Preanalytical Paths
Final principle
Serum and plasma may both appear as a clear upper liquid phase after centrifugation, but they begin from different sample states and can have different downstream quality requirements.
A professional centrifugation method therefore does not begin by asking for a “standard serum RPM” or “standard plasma time.”
It begins with the exact tube and analytical target, then defines RCF, time, rotor geometry, temperature and deceleration as one controlled workflow.
Technical reference framework
WHO laboratory and blood-quality guidance: specimen preparation, centrifugation process control and blood-component handling principles.
CLSI preexamination guidance: blood collection tubes, additives, temperature, centrifugal force and run-time considerations.
Public biomedical research indexed in PubMed/PMC: serum/plasma preanalytical variability, residual platelet control, rotor geometry and specimen-processing effects.
GlanLab current YT5A specifications and rotor configurations.
GlanLab, with over 20 years of experience, manufactures a full range of centrifuge machines, including benchtop, high-speed, floor-standing, and specialized models in China. We offer distribution, wholesale, OEM services, and single-unit orders at competitive prices. With complete quality certifications and robust after-sales support, GlanLab is your trusted partner for centrifuge supplies.
